Think Surgical marketing image of its TMINI handheld ortho surgical robotThink Surgical announced two new collaborations surrounding surgical robotics and implants for total knee arthroplasty (TKA).

The company inked new collaborations with Maxx Orthopedics and b-ONE Ortho Corp. over the past two days. These deals come just days after the company announced a partnership with Waldemar Link on the same front.

First, in collaboration with Maxx, Think Surgical plans to add Maxx’s implants to its TMINI miniature surgical robotic system. The deal brings the Freedom knee system for total knee arthroplasty to Think Surgical’s ID-HUB. ID-HUB serves as a proprietary database of implant modules for use with TMINI. The database already includes five implant systems from other manufacturers, including the one added from Link this week.

Think also added b-ONE implants, including the Mobio total knee system.

TMINI received FDA clearance in May 2023. It features a wireless, robotic handpiece that assists surgeons in performing total knee replacement. Following a CT-based three-dimensional surgical plan, the TMINI robotic handpiece automatically compensates for the surgeon’s hand movement to locate bone pins along precisely defined planes. Cutting guides are then connected to the bone pins for accurate bone resection.

Think Surgical says adding more implants to the database enhances the customers’ choice of implant options when using TMINI.

On the Maxx collaboration, Think Surgical President and CEO Stuart Simpson said: “We are delighted to welcome Maxx Orthopedics to the TMINI platform.  Their commitment to delivering creative and efficient solutions to customers complements THINK Surgical’s mission to provide customers with greater choice in patient treatment options.”

Simpson also commented on the b-ONE partnership: “b-ONEs’ commitment to improving the experience of both patients and surgeons through innovative technologies aligns well with our value proposition for the TMINI system. We look forward to providing customers further choice in patient treatment through our collaboration.”